AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36366817 — intervention group
Group type: COMPARATOR
Intervention: One-limb mask
Number of subjects: 10
Study 34420922 — intervention group
Group type: EXPERIMENTAL
Intervention: MibyeongBogam (MBBG) app
Number of subjects: 150
Study 34420922 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 32420683 — intervention group
Group type: EXPERIMENTAL
Intervention: Lentils
Number of subjects: 11
Study 32420683 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpeas
Number of subjects: 11
Study 32420683 — intervention group
Group type: EXPERIMENTAL
Intervention: White Beans
Number of subjects: 11
Study 32420683 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial metabolites
Number of subjects: 11
Study 32420683 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 h urine samples
Number of subjects: 11
Study 35168581 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS technology
Number of subjects: 314
Study 35168581 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 314
Study 35168581 — intervention group
Group type: EXPERIMENTAL
Intervention: WBOTs
Number of subjects: 314
Study 34134131 — intervention group
Group type: EXPERIMENTAL
Intervention: PCE risk score
Number of subjects: 7382
Study 34134131 — intervention group
Group type: EXPERIMENTAL
Intervention: LS7 score
Number of subjects: 7382
Study 32118713 — intervention group
Group type: EXPERIMENTAL
Intervention: HP and PHVHF group
Number of subjects: 30
Study 32118713 — intervention group
Group type: COMPARATOR
Intervention: CVVH group
Number of subjects: 30
Study 36316932 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg nicotinamide 5 times a day for 2 days
Number of subjects: 24
Study 36316932 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment only
Number of subjects: 24
Study 33977745 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive bias modification (CBM) for attention and interpretation training plus routine training
Number of subjects: 100
Study 33977745 — intervention group
Group type: COMPARATOR
Intervention: Routine training
Number of subjects: 100
Study 35315603 — intervention group
Group type: EXPERIMENTAL
Intervention: DA‐2802 (tenofovir disoproxil orotate) at a dose of 319 mg once daily for 48 weeks
Number of subjects: 122
Study 35315603 — intervention group
Group type: COMPARATOR
Intervention: Viread® (tenofovir disoproxil fumarate) at a dose of 300 mg once daily for 48 weeks
Number of subjects: 122
Study 35315603 — intervention group
Group type: EXPERIMENTAL
Intervention: DA‐2802
Number of subjects: 122
Study 35315603 — intervention group
Group type: COMPARATOR
Intervention: Viread®
Number of subjects: 122
Study 35315603 — intervention group
Group type: EXPERIMENTAL
Intervention: DA‐2802 and Viread®
Number of subjects: 122
Study 32462992 — intervention group
Group type: EXPERIMENTAL
Intervention: Recounting (n=16)
Number of subjects: 32
Study 32462992 — intervention group
Group type: COMPARATOR
Intervention: Suppression (n=16)
Number of subjects: 32
Study 32462992 — intervention group
Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 32
Study 35085018 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture and lavender oil aromatherapy (verum group, n=39)
Number of subjects: 80
Study 35085018 — intervention group
Group type: COMPARATOR
Intervention: Combined sham auricular acupuncture and placebo oil aromatherapy (placebo group, n=41)
Number of subjects: 80
Study 35085018 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture and lavender oil aromatherapy (verum group)
Number of subjects: 80
Study 35085018 — intervention group
Group type: COMPARATOR
Intervention: Combined sham auricular acupuncture and placebo oil aromatherapy (placebo group)
Number of subjects: 80
Study 32017322 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (40 min, twice a week for 12 months)
Number of subjects: 37
Study 32017322 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 37
Study 33736670 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation group 1 - received an evidence-based policy recommendation document guiding weekend allied health resource allocation decisions
Number of subjects: 80
Study 33736670 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation group 2 - received the same policy recommendation document with support from a knowledge broker
Number of subjects: 80
Study 33736670 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 34483325 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancellous screws (CSs)
Number of subjects: 819
Study 34483325 — intervention group
Group type: COMPARATOR
Intervention: Sliding hip screws
Number of subjects: 819
Study 34483325 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma‐fellowship‐trained surgeons
Number of subjects: 819
Study 34483325 — intervention group
Group type: COMPARATOR
Intervention: Non‐trauma‐fellowship‐trained surgeons
Number of subjects: 819
Study 34770157 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Energy Restriction (CER)
Number of subjects: 26
Study 34770157 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Energy Restriction (IER)
Number of subjects: 26
Study 34770157 — intervention group
Group type: COMPARATOR
Intervention: Control (CERG)
Number of subjects: 26
Study 34770157 — intervention group
Group type: COMPARATOR
Intervention: Control (between groups)
Number of subjects: 26
Study 32034849 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help materials with usual care (n=336)
Number of subjects: 678
Study 32034849 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (n=342)
Number of subjects: 678
Study 35761123 — intervention group
Group type: EXPERIMENTAL
Intervention: P-FOLFIRI (arm A)
Number of subjects: 31
Study 35761123 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI alone (arm B)
Number of subjects: 31
Study 33449503 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned open-label placebo (COLP)
Number of subjects: 0
Study 33449503 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 0
Study 34459996 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoyam
Number of subjects: 0
Study 34459996 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantain
Number of subjects: 0
Study 34459996 — intervention group
Group type: COMPARATOR
Intervention: Control (WHO recommended limits)
Number of subjects: 0
Study 34459996 — intervention group
Group type: COMPARATOR
Intervention: Daily Intake of Metals (DIM) and Target Hazard Quotient (THQ)
Number of subjects: 0
Study 34459996 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime probability of contracting cancer
Number of subjects: 0
Study 36459338 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US) group, hemodynamic management guided with clinical parameters and bedside US findings
Number of subjects: 111
Study 36459338 — intervention group
Group type: COMPARATOR
Intervention: Control group, hemodynamic management based solely on clinical parameters
Number of subjects: 111
Study 34193504 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (10 mg/day and 22.5 mg/day)
Number of subjects: 6
Study 34193504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 34193504 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 6
Study 32957356 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention based on motivational interview
Number of subjects: 60
Study 32957356 — intervention group
Group type: COMPARATOR
Intervention: Control group (informative session only)
Number of subjects: 60
Study 32957356 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (control and experimental)
Number of subjects: 60
Study 35451858 — intervention group
Group type: EXPERIMENTAL
Intervention: galcanezumab 120 mg/month (following a 240 mg loading dose)
Number of subjects: 462
Study 35451858 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 462
Study 35451858 — intervention group
Group type: EXPERIMENTAL
Intervention: galcanezumab
Number of subjects: 462
Study 34614118 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home bleaching (10% carbamide peroxide)
Number of subjects: 130
Study 34614118 — intervention group
Group type: COMPARATOR
Intervention: In-office bleaching (35% hydrogen peroxide)
Number of subjects: 130
Study 32541837 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation warning (only warned of a perturbation)
Number of subjects: 30
Study 32541837 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation exposure (exposed to fifty unilateral slip-like perturbations)
Number of subjects: 30
Study 32541837 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation removal (kept unaware of perturbation removal)
Number of subjects: 30
Study 35764992 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy food nudges and pricing strategies
Number of subjects: 360
Study 35764992 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving no intervention
Number of subjects: 360
Study 33318119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory oxygen therapy using a portable oxygen concentrator (POC) during daily activities
Number of subjects: 0
Study 33318119 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory air using an identical POC modified to deliver air
Number of subjects: 0
Study 33318119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory oxygen therapy
Number of subjects: 0
Study 33318119 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory air
Number of subjects: 0
Study 35589170 — intervention group
Group type: COMPARATOR
Intervention: Circumferential pulmonary vein isolation (CPVI) alone
Number of subjects: 150
Study 35589170 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional electrical posterior box isolation (POBI)
Number of subjects: 150
Study 34089147 — intervention group
Group type: EXPERIMENTAL
Intervention: AS MDI (90 μg/inhalation, cumulative doses up to 1440 μg)
Number of subjects: 132
Study 34089147 — intervention group
Group type: EXPERIMENTAL
Intervention: AS MDI (90 μg and 180 μg)
Number of subjects: 132
Study 34089147 — intervention group
Group type: EXPERIMENTAL
Intervention: Proventil (90 μg and 180 μg)
Number of subjects: 132
Study 35870076 — intervention group
Group type: COMPARATOR
Intervention: Control app (ultraviolet index only)
Number of subjects: 59
Study 35870076 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun4Health® app (personalised recommendations and sun overexposure alerts)
Number of subjects: 59
Study 35870076 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun4Health®-3D app (personalised recommendations connected to a wearable device)
Number of subjects: 59
Study 35870076 — intervention group
Group type: COMPARATOR
Intervention: Control app
Number of subjects: 59
Study 35870076 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun4Health® app
Number of subjects: 59
Study 35870076 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun4Health®-3D app
Number of subjects: 59
Study 33938254 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing records analyzed using document vector analysis for predicting aspiration pneumonia onset.
Number of subjects: 0
Study 33938254 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing records for the patient group with aspiration pneumonia.
Number of subjects: 0
Study 33938254 — intervention group
Group type: COMPARATOR
Intervention: Nursing records for the non-onset control group.
Number of subjects: 0
Study 33231638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 2796
Study 33231638 — intervention group
Group type: COMPARATOR
Intervention: Control group (diabetes support and education)
Number of subjects: 2796
Study 35168010 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR)
Number of subjects: 40
Study 35168010 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 40
Study 33199419 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC) performed by inflating a thigh tourniquet to 300 mm Hg 4 times for 5 min, done two times: first after declaration of brain death and second before transferring to the operating theatre.
Number of subjects: 500
Study 33199419 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention (tourniquet applied but not inflated).
Number of subjects: 500
Study 33199419 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC intervention
Number of subjects: 500
Study 32687695 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitafloxacin granules 50 mg single dose
Number of subjects: 0
Study 32687695 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitafloxacin granules 100 mg single dose
Number of subjects: 0
Study 32687695 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitafloxacin granules 200 mg single dose
Number of subjects: 0
Study 32687695 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitafloxacin granules 50 mg with high-fat meal
Number of subjects: 0
Study 32687695 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitafloxacin granules 100 mg once daily for 5 days
Number of subjects: 0
Study 32687695 — intervention group
Group type: COMPARATOR
Intervention: ABCB1 (rs1045642) mutation group
Number of subjects: 0
Study 32687695 — intervention group
Group type: COMPARATOR
Intervention: UGT1A1 (rs2741049) mutation group
Number of subjects: 0
Study 32687695 — intervention group
Group type: COMPARATOR
Intervention: UGT1A9 (rs3832043) mutation group
Number of subjects: 0
Study 32513291 — intervention group
Group type: EXPERIMENTAL
Intervention: MoVo‐LISA plus MoVo‐App
Number of subjects: 224
Study 32513291 — intervention group
Group type: COMPARATOR
Intervention: MoVo‐LISA alone (without the app)
Number of subjects: 224
Study 33870728 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL cholesterol efflux
Number of subjects: 446
Study 33870728 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory capacity
Number of subjects: 446
Study 33870728 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidative capacity
Number of subjects: 446
Study 33870728 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL cholesterol concentrations
Number of subjects: 446
Study 33870728 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL functionality measures
Number of subjects: 446
Study 32701903 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg/d)
Number of subjects: 71
Study 32701903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 34864274 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified long-axis in-plane ultrasound guidance (M-LAIP)
Number of subjects: 201
Study 34864274 — intervention group
Group type: COMPARATOR
Intervention: Short-axis out-of-plane (SAOP)
Number of subjects: 201
Study 34864274 — intervention group
Group type: COMPARATOR
Intervention: Conventional palpation (C-P)
Number of subjects: 201
Study 33273349 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 455
Study 33273349 — intervention group
Group type: COMPARATOR
Intervention: Immediate surgery (control group)
Number of subjects: 455
Study 35933563 — intervention group
Group type: EXPERIMENTAL
Intervention: PKP combined with zoledronic acid (ZOL)
Number of subjects: 238
Study 35933563 — intervention group
Group type: COMPARATOR
Intervention: PKP only (control group)
Number of subjects: 238
Study 33413631 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal desensitisation plus motivational interviewing (IDMI) intervention
Number of subjects: 60
Study 33413631 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 60
Study 36859448 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Community Programme (HLCP) - 14 seminars (twice per week), stress-regulation and cooking workshops, coaching sessions for healthy plant-based diet, stress regulation, regular exercise, social support.
Number of subjects: 143
Study 36859448 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no specific intervention details provided.
Number of subjects: 143
Study 36859448 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Community Programme (HLCP) - 8-week intervention.
Number of subjects: 143
Study 34521624 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole (A)
Number of subjects: 432
Study 34521624 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole plus fulvestrant (A+F)
Number of subjects: 432
Study 34521624 — intervention group
Group type: EXPERIMENTAL
Intervention: High sTK1 at baseline and subsequent time-points
Number of subjects: 432
Study 34332429 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Coping Awareness Therapy (I-CAT)
Number of subjects: 36
Study 34332429 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 36
Study 34419680 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 850
Study 34419680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 850
Study 32828825 — intervention group
Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 431
Study 32828825 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 431
Study 33546045 — intervention group
Group type: EXPERIMENTAL
Intervention: Shexiang Baoxin Pill combined with Western medicine
Number of subjects: 0
Study 33546045 — intervention group
Group type: COMPARATOR
Intervention: Routine Western medicine
Number of subjects: 0
Study 35334923 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vitamin D sufficiency
Number of subjects: 0
Study 32961065 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT plus lifestyle education (HIIT+)
Number of subjects: 41
Study 32961065 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 41
Study 32864760 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% cysteamine
Number of subjects: 40
Study 32864760 — intervention group
Group type: COMPARATOR
Intervention: 4% hydroquinone
Number of subjects: 40
Study 35893858 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-MNA supplementation
Number of subjects: 50
Study 35893858 — intervention group
Group type: COMPARATOR
Intervention: NO-1-MNA (control group)
Number of subjects: 50
Study 32768182 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully guided protocol (24 implants)
Number of subjects: 12
Study 35264114 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants based on individual single nucleotide polymorphisms (SNPs) and a 27 SNP genetic risk score (GRS) derived from SNPs strongly associated with CHD
Number of subjects: 4932
Study 35264114 — intervention group
Group type: EXPERIMENTAL
Intervention: 27 SNP genetic risk score (GRS)
Number of subjects: 4932
Study 34719269 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand removal (ODR) of syndesmotic screws
Number of subjects: 197
Study 34719269 — intervention group
Group type: COMPARATOR
Intervention: Routine removal (RR) of syndesmotic screws
Number of subjects: 197
Study 35787516 — intervention group
Group type: EXPERIMENTAL
Intervention: SM+FB (Self-Monitoring plus Feedback)
Number of subjects: 502
Study 35787516 — intervention group
Group type: COMPARATOR
Intervention: SM (Self-Monitoring only)
Number of subjects: 502
Study 35787516 — intervention group
Group type: EXPERIMENTAL
Intervention: FB messages opened
Number of subjects: 502
Study 32971190 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 10142
Study 32971190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10142
Study 32828117 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal steroid (fluticasone furoate, 110 mcg/day)
Number of subjects: 34
Study 32828117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 32501868 — intervention group
Group type: EXPERIMENTAL
Intervention: OPRX-106 2 mg administered orally once daily for 8 weeks
Number of subjects: 25
Study 32501868 — intervention group
Group type: EXPERIMENTAL
Intervention: OPRX-106 8 mg administered orally once daily for 8 weeks
Number of subjects: 25
Study 32501868 — intervention group
Group type: EXPERIMENTAL
Intervention: OPRX-106 (both dosages)
Number of subjects: 25
Study 34027992 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided phrenic nerve block (ropivacaine 0.75 mg/mL)
Number of subjects: 12
Study 34027992 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic sodium chloride 0.9 mg/mL)
Number of subjects: 12
Study 32546198 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic HRQoL assessment using the CHES software before each consultation coupled with therapeutic information (three workshops related to understanding the prescription, nutrition, and fatigue)
Number of subjects: 342
Study 32546198 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 342
Study 32546198 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic HRQoL assessment
Number of subjects: 342
Study 32546198 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine HRQoL assessment
Number of subjects: 342
Study 36042217 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop insulin delivery system
Number of subjects: 42
Study 36042217 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetes care
Number of subjects: 42
Study 33831710 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive suppression
Number of subjects: 117
Study 33831710 — intervention group
Group type: COMPARATOR
Intervention: Cognitive reappraisal
Number of subjects: 117
Study 34415801 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler echocardiography (Doppler‐CO)
Number of subjects: 141
Study 34415801 — intervention group
Group type: COMPARATOR
Intervention: Thermodilution using pulmonary artery catheters (PAC‐CO)
Number of subjects: 141
Study 33858855 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 26
Study 99370165 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha (6 MU given three times a week)
Number of subjects: 15
Study 99370165 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN plus ribavirin
Number of subjects: 15
Study 99370165 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (IFN plus ribavirin)
Number of subjects: 15
Study 99370165 — intervention group
Group type: COMPARATOR
Intervention: IFN alone
Number of subjects: 15
Study 34120135 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-Mounted Display (HMD) simulation
Number of subjects: 115